Abstracts Archive - Page 541 of 1683 - ATC Abstracts

2020 American Transplant Congress
Testing Deceased Organ Donors for Infections: An Organ Procurement Organization (OPO) Survey
N. M. Theodoropoulos¹, P. Chin-Hong², M. Greenwald³, M. G. Ison⁴
¹University of Massachusetts Medical School, Worcester, MA, ²UCSF, San Francisco, CA, ³Uniformed Services University School of Medicine, Bethesda, MD, ⁴Northwestern University, Chicago, IL
*Purpose: We surveyed the 58 U.S. OPOs to update our knowledge about the current methods of infectious disease testing in deceased organ donors.*Methods: An IRB…
2020 American Transplant Congress
Willingness to Accept and Beliefs Regarding Organs from HIV-Infected Donors: A Multi-Center Survey of Transplant Candidates Living with HIV
S. Rasmussen¹, S. Seaman¹, M. Bowring¹, D. Brown¹, A. Massie¹, A. Tobian¹, M. Henderson¹, F. Fletcher², B. Smith², A. Chao³, N. Gorupati³, K. Prakash⁴, S. Aslam⁴, D. Lee⁵, S. Trinh⁶, V. Kirchner⁷, T. Pruett⁷, G. Haidar⁸, K. Hughes⁸, M. Malinis⁹, D. Segev¹, J. Sugarman¹, C. Durand¹
¹JHU, Baltimore, MD, ²UAB, Birmingham, AL, ³UCSF, San Francisco, CA, ⁴UCSD, San Diego, CA, ⁵Drexel, Philadelphia, PA, ⁶Ochsner, New Orleans, LA, ⁷UMN, Minneapolis, MN, ⁸UPMC, Pittsburgh, PA, ⁹Yale, New Haven, CT
*Purpose: HIV-infected (HIV+) donor to HIV+ recipient (HIV D+/R+) transplantation might improve access to transplantation for candidates living with HIV. However, it is unclear whether…
2020 American Transplant Congress
Association between Mycoplasma and Ureaplasma Airway Colonization, Ammonia Levels and Outcomes Post Lung Transplantation
B. Buzo¹, J. Preiksaitis¹, K. Halloran², J. Nagendran³, D. Townsend⁴, N. Zelyas⁵, W. Sligl⁴
¹Infectious Diseases, Univ. of Alberta, Edmonton, AB, Canada, ²Pulmonary Medicine, Univ. of Alberta, Edmonton, AB, Canada, ³Cardiac Surgery, Univ. of Alberta, Edmonton, AB, Canada, ⁴Critical Care Medicine, Univ. of Alberta, Edmonton, AB, Canada, ⁵Lab Med & Pathology, Univ. of Alberta, Edmonton, AB, Canada
*Purpose: Hyperammonemia syndrome (HS) is a rare complication that can occur after lung transplantation. This syndrome is characterized by increased ammonia levels with altered sensorium,…
2020 American Transplant Congress
Outcomes of Kidney Transplant Patients Evaluated, Listed and Managed Using A Distant Transplant Outreach Care Model (DTrOM)
M. Mujtaba, M. Kueht, S. Hussain, A. Rizvi, S. Shah, R. Kulkarni, S. N. Merwat, A. Gamilla-Crudo, K. Gugliuzza, J. Fair
UTMB, Galveston, TX
*Purpose: All advanced kidney disease and post-transplant patients are not always fortunate enough to be living close to a transplant care center. To this end,…
2020 American Transplant Congress
Assessing Interventions to Improve Patient Care Conducted by Pharmacists at an Outpatient Renal Transplant Clinic within a Collaborative Pharmacy Practice Agreement
K. Johnson, R. Chelewski, A. Langone, M. Peter, A. Zuckerman
Vanderbilt University Medical Center, Nashville, TN
*Purpose: A collaborative pharmacy practice agreement (CPPA) permits pharmacists to perform clinical services under the guidance of a supervising physician without direct physician intervention. We…
2020 American Transplant Congress
Peer Feedback Improves Nephrologists’ Transplant Referral Practices
A. Padiyar, T. Srinivas
Medicine, University Hospitals Cleveland Medical Center, Cleveland, OH
*Purpose: While preemptive kidney transplant is associated with superior outcomes, timely referral remains a significant barrier. Peer feedback may help improve practice. Our hypothesis is…
2020 American Transplant Congress
Textbook Outcome as a Composite Quality Metric in Kidney Transplantation
J. L. Han, A. J. Logan, J. M. Sneddon, G. L. Brock, K. W. Washburn, A. D. Schenk
Department of Surgery, Division of Transplantation, The Ohio State University Wexner Medical Center, Columbus, OH
*Purpose: Textbook outcomes (TO) describe ideal patient outcomes following specific surgical procedures and are useful composite quality metrics for patients, providers and payors. We aimed…
2020 American Transplant Congress
Outcomes of Hiv-Positive Patients Post-Cardiac Transplantation
G. S. Liu¹, A. M. Wolfson², A. D. Salimbangon³, R. R. Chand⁴, P. Banankhah¹, J. Nattiv¹, P. A. Genyk¹, P. A. Kingsford¹, J. P. Li¹, D. Vucicevic⁵, K. Pandya¹, J. Rahman¹, M. Fong¹, E. C. DePasquale¹, A. S. Vaidya¹
¹Keck Medicine of USC, Los Angeles, CA, ²University of Arizona Sarver Heart Center, Tucson, AZ, ³UCLA Medical Center, Los Angeles, CA, ⁴Harbor-UCLA Medical Center, Los Angeles, CA, ⁵Newark Beth-Israel Medical Center, Newark, NJ
*Purpose: Human immunodeficiency virus (HIV) infection is no longer an absolute contraindication to heart transplantation (HT) in many HT centers, but long-term post-HT outcomes of…
2020 American Transplant Congress
Heart Transplant Outcomes in Patients Who Receive Hepatitis B Virus-Positive Donor Hearts: A UNOS Registry Analysis
P. Genyk¹, K. Yang², R. Chand³, E. Depasquale¹
¹Keck Medicine of USC, Los Angeles, CA, ²Keck Medicine of USC, South Pasadena, CA, ³Harbor-UCLA Medical Center, Los Angeles, CA
*Purpose: Hepatitis B infection in post-transplant patients posed a challenge in the setting of immunosuppression. However, the advent of anti-viral therapy for HBV has made…
2020 American Transplant Congress
Three-Year Post-Transplant Outcome of Desensitized Mechanical Circulatory Support Patients Awaiting Heart Transplantation
J. Youn¹, R. Cole², D. Ramzy², E. Kim¹, J. Kobashigawa², J. Moriguchi²
¹Seoul St. Mary's Hospital, Seoul, Korea, Republic of, ²Cedars-Sinai Heart Institute, Los Angeles, CA
*Purpose: Up to 30% of durable mechanical circulatory support (MCS) patients (pts) develop panel reactive antibody (PRA) screen >= 10%. In our program, desensitization (DS)…